Skip to main content
Log in

Adalimumab/etanercept/methotrexate

Cutaneous leishmaniasis: 6 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Martinez-Domenech A, et al. Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience. British Journal of Dermatology 181: 403-405, No. 2, Aug 2019. Available from: URL: http://doi.org/10.1111/bjd.17644 - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/etanercept/methotrexate. Reactions Weekly 1769, 20 (2019). https://doi.org/10.1007/s40278-019-67034-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-67034-5

Navigation